Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Piro

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1991
2-Chlorodeoxyadenosine chemotherapy triggers programmed cell death in normal and malignant lymphocytesC J Carrera, L D Piro, A Saven, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|October 26, 1999
Implant brachytherapy: a novel treatment for recurrent orbital rhabdomyosarcomaD H Abramson, D Fass, B McCormick, et al.
Blood|February 1, 1993
Relationship of deoxycytidine kinase and cytoplasmic 5'-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosineH Kawasaki, C J Carrera, L D Piro, et al.
American Journal of Clinical Pathology|November 1, 1994
Identification of monoclonal immunoglobulins and quantitative immunoglobulin abnormalities in hairy cell leukemia and chronic lymphocytic leukemiaD A Hansen, B A Robbins, D J Bylund, et al.
Antibiotics & Chemotherapy (Northfield, Ill.)|February 19, 2014
Cross-correlation of bacterial sensitivity to carbomycin and erythromycin compared with other antibioticsA H KUTSCHER, L SEGUIN, S LEWIS, et al.
Cancer|June 15, 1994
Complete hematologic remissions in chronic-phase, Philadelphia-chromosome-positive, chronic myelogenous leukemia after 2-chlorodeoxyadenosineA Saven, L D Piro, R H Lemon, et al.
The Journal of Clinical Investigation|November 1, 1990
Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapyC J Carrera, C Terai, M Lotz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
2-Chlorodeoxyadenosine treatment of low-grade lymphomasA C Kay, A Saven, C J Carrera, et al.
Technical Innovations & Patient Support in Radiation Oncology|July 3, 2020
Radiation therapy technologists' involvement and opinion in research: A national survey in ItalyD Piro, L Boldrini, P Cornacchione, et al.
International Journal of Neonatal Screening|July 21, 2021
Newborn Screening for Severe Combined Immunodeficiency Using the Multiple of the Median Values of T-Cell Receptor Excision CirclesMichael F Cogley, Amy E Wiberley-Bradford, Sean T Mochal, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Advances in Experimental Medicine and Biology|January 1, 1991
2-Chlorodeoxyadenosine chemotherapy triggers programmed cell death in normal and malignant lymphocytesC J Carrera, L D Piro, A Saven, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|October 26, 1999
Implant brachytherapy: a novel treatment for recurrent orbital rhabdomyosarcomaD H Abramson, D Fass, B McCormick, et al.
Blood|February 1, 1993
Relationship of deoxycytidine kinase and cytoplasmic 5'-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosineH Kawasaki, C J Carrera, L D Piro, et al.
American Journal of Clinical Pathology|November 1, 1994
Identification of monoclonal immunoglobulins and quantitative immunoglobulin abnormalities in hairy cell leukemia and chronic lymphocytic leukemiaD A Hansen, B A Robbins, D J Bylund, et al.
Antibiotics & Chemotherapy (Northfield, Ill.)|February 19, 2014
Cross-correlation of bacterial sensitivity to carbomycin and erythromycin compared with other antibioticsA H KUTSCHER, L SEGUIN, S LEWIS, et al.
Cancer|June 15, 1994
Complete hematologic remissions in chronic-phase, Philadelphia-chromosome-positive, chronic myelogenous leukemia after 2-chlorodeoxyadenosineA Saven, L D Piro, R H Lemon, et al.
The Journal of Clinical Investigation|November 1, 1990
Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapyC J Carrera, C Terai, M Lotz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
2-Chlorodeoxyadenosine treatment of low-grade lymphomasA C Kay, A Saven, C J Carrera, et al.
Technical Innovations & Patient Support in Radiation Oncology|July 3, 2020
Radiation therapy technologists' involvement and opinion in research: A national survey in ItalyD Piro, L Boldrini, P Cornacchione, et al.
International Journal of Neonatal Screening|July 21, 2021
Newborn Screening for Severe Combined Immunodeficiency Using the Multiple of the Median Values of T-Cell Receptor Excision CirclesMichael F Cogley, Amy E Wiberley-Bradford, Sean T Mochal, et al.
Pageof 9